Global Oral TYK2 Inhibitor Market Growth (Status and Outlook) 2026-2032

August 2026 | 85 pages | ID: GB051E3CFF85EN
LP Information

Abstracts

The global Oral TYK2 Inhibitor market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Oral TYK2 Inhibitor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Oral TYK2 Inhibitor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Oral TYK2 Inhibitor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Oral TYK2 Inhibitor players cover Bristol-Myers Squibb, InnoCare Pharma, Takeda (Nimbus Therapeutics), E-nitiate Biopharmaceuticals, Highlightll Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the ?Oral TYK2 Inhibitor Industry Forecast? looks at past sales and reviews total world Oral TYK2 Inhibitor sales in 2025, providing a comprehensive analysis by region and market sector of projected Oral TYK2 Inhibitor sales for 2026 through 2032. With Oral TYK2 Inhibitor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral TYK2 Inhibitor industry.

This Insight Report provides a comprehensive analysis of the global Oral TYK2 Inhibitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oral TYK2 Inhibitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Oral TYK2 Inhibitor market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral TYK2 Inhibitor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral TYK2 Inhibitor.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral TYK2 Inhibitor market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Single-target Inhibitor
• Dual-target Inhibitor

Segmentation by Application:

• Psoriasis
• Atopic Dermatitis
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bristol-Myers Squibb
• InnoCare Pharma
• Takeda (Nimbus Therapeutics)
• E-nitiate Biopharmaceuticals
• Highlightll Pharmaceutical
• Pfizer
• Alumis Inc.
• Galapagos NV
• Ventyx Biosciences

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oral TYK2 Inhibitor Market Size (2021-2032)
  2.1.2 Oral TYK2 Inhibitor Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Oral TYK2 Inhibitor by Country/Region (2021, 2025 & 2032)
2.2 Oral TYK2 Inhibitor Segment by Type
  2.2.1 Single-target Inhibitor
  2.2.2 Dual-target Inhibitor
  2.2.3 Oral TYK2 Inhibitor Market Size by Type
    2.2.3.1 Oral TYK2 Inhibitor Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Oral TYK2 Inhibitor Market Size Market Share by Type (2021-2026)
2.3 Oral TYK2 Inhibitor Segment by Application
  2.3.1 Psoriasis
  2.3.2 Atopic Dermatitis
  2.3.3 Other
  2.3.4 Oral TYK2 Inhibitor Market Size by Application
    2.3.4.1 Oral TYK2 Inhibitor Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Oral TYK2 Inhibitor Market Size Market Share by Application (2021-2026)

3 ORAL TYK2 INHIBITOR MARKET SIZE BY PLAYER

3.1 Oral TYK2 Inhibitor Market Size Market Share by Player
  3.1.1 Global Oral TYK2 Inhibitor Revenue by Player (2021-2026)
  3.1.2 Global Oral TYK2 Inhibitor Revenue Market Share by Player (2021-2026)
3.2 Global Oral TYK2 Inhibitor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ORAL TYK2 INHIBITOR BY REGION

4.1 Oral TYK2 Inhibitor Market Size by Region (2021-2026)
4.2 Global Oral TYK2 Inhibitor Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oral TYK2 Inhibitor Market Size Growth (2021-2026)
4.4 APAC Oral TYK2 Inhibitor Market Size Growth (2021-2026)
4.5 Europe Oral TYK2 Inhibitor Market Size Growth (2021-2026)
4.6 Middle East & Africa Oral TYK2 Inhibitor Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Oral TYK2 Inhibitor Market Size by Country (2021-2026)
5.2 Americas Oral TYK2 Inhibitor Market Size by Type (2021-2026)
5.3 Americas Oral TYK2 Inhibitor Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oral TYK2 Inhibitor Market Size by Region (2021-2026)
6.2 APAC Oral TYK2 Inhibitor Market Size by Type (2021-2026)
6.3 APAC Oral TYK2 Inhibitor Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Oral TYK2 Inhibitor Market Size by Country (2021-2026)
7.2 Europe Oral TYK2 Inhibitor Market Size by Type (2021-2026)
7.3 Europe Oral TYK2 Inhibitor Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oral TYK2 Inhibitor by Region (2021-2026)
8.2 Middle East & Africa Oral TYK2 Inhibitor Market Size by Type (2021-2026)
8.3 Middle East & Africa Oral TYK2 Inhibitor Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ORAL TYK2 INHIBITOR MARKET FORECAST

10.1 Global Oral TYK2 Inhibitor Forecast by Region (2027-2032)
  10.1.1 Global Oral TYK2 Inhibitor Forecast by Region (2027-2032)
  10.1.2 Americas Oral TYK2 Inhibitor Forecast
  10.1.3 APAC Oral TYK2 Inhibitor Forecast
  10.1.4 Europe Oral TYK2 Inhibitor Forecast
  10.1.5 Middle East & Africa Oral TYK2 Inhibitor Forecast
10.2 Americas Oral TYK2 Inhibitor Forecast by Country (2027-2032)
  10.2.1 United States Market Oral TYK2 Inhibitor Forecast
  10.2.2 Canada Market Oral TYK2 Inhibitor Forecast
  10.2.3 Mexico Market Oral TYK2 Inhibitor Forecast
  10.2.4 Brazil Market Oral TYK2 Inhibitor Forecast
10.3 APAC Oral TYK2 Inhibitor Forecast by Region (2027-2032)
  10.3.1 China Oral TYK2 Inhibitor Market Forecast
  10.3.2 Japan Market Oral TYK2 Inhibitor Forecast
  10.3.3 Korea Market Oral TYK2 Inhibitor Forecast
  10.3.4 Southeast Asia Market Oral TYK2 Inhibitor Forecast
  10.3.5 India Market Oral TYK2 Inhibitor Forecast
  10.3.6 Australia Market Oral TYK2 Inhibitor Forecast
10.4 Europe Oral TYK2 Inhibitor Forecast by Country (2027-2032)
  10.4.1 Germany Market Oral TYK2 Inhibitor Forecast
  10.4.2 France Market Oral TYK2 Inhibitor Forecast
  10.4.3 UK Market Oral TYK2 Inhibitor Forecast
  10.4.4 Italy Market Oral TYK2 Inhibitor Forecast
  10.4.5 Russia Market Oral TYK2 Inhibitor Forecast
10.5 Middle East & Africa Oral TYK2 Inhibitor Forecast by Region (2027-2032)
  10.5.1 Egypt Market Oral TYK2 Inhibitor Forecast
  10.5.2 South Africa Market Oral TYK2 Inhibitor Forecast
  10.5.3 Israel Market Oral TYK2 Inhibitor Forecast
  10.5.4 Turkey Market Oral TYK2 Inhibitor Forecast
10.6 Global Oral TYK2 Inhibitor Forecast by Type (2027-2032)
10.7 Global Oral TYK2 Inhibitor Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Oral TYK2 Inhibitor Forecast

11 KEY PLAYERS ANALYSIS

11.1 Bristol-Myers Squibb
  11.1.1 Bristol-Myers Squibb Company Information
  11.1.2 Bristol-Myers Squibb Oral TYK2 Inhibitor Product Offered
  11.1.3 Bristol-Myers Squibb Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Bristol-Myers Squibb Main Business Overview
  11.1.5 Bristol-Myers Squibb Latest Developments
11.2 InnoCare Pharma
  11.2.1 InnoCare Pharma Company Information
  11.2.2 InnoCare Pharma Oral TYK2 Inhibitor Product Offered
  11.2.3 InnoCare Pharma Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 InnoCare Pharma Main Business Overview
  11.2.5 InnoCare Pharma Latest Developments
11.3 Takeda (Nimbus Therapeutics)
  11.3.1 Takeda (Nimbus Therapeutics) Company Information
  11.3.2 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitor Product Offered
  11.3.3 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Takeda (Nimbus Therapeutics) Main Business Overview
  11.3.5 Takeda (Nimbus Therapeutics) Latest Developments
11.4 E-nitiate Biopharmaceuticals
  11.4.1 E-nitiate Biopharmaceuticals Company Information
  11.4.2 E-nitiate Biopharmaceuticals Oral TYK2 Inhibitor Product Offered
  11.4.3 E-nitiate Biopharmaceuticals Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 E-nitiate Biopharmaceuticals Main Business Overview
  11.4.5 E-nitiate Biopharmaceuticals Latest Developments
11.5 Highlightll Pharmaceutical
  11.5.1 Highlightll Pharmaceutical Company Information
  11.5.2 Highlightll Pharmaceutical Oral TYK2 Inhibitor Product Offered
  11.5.3 Highlightll Pharmaceutical Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Highlightll Pharmaceutical Main Business Overview
  11.5.5 Highlightll Pharmaceutical Latest Developments
11.6 Pfizer
  11.6.1 Pfizer Company Information
  11.6.2 Pfizer Oral TYK2 Inhibitor Product Offered
  11.6.3 Pfizer Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Pfizer Main Business Overview
  11.6.5 Pfizer Latest Developments
11.7 Alumis Inc.
  11.7.1 Alumis Inc. Company Information
  11.7.2 Alumis Inc. Oral TYK2 Inhibitor Product Offered
  11.7.3 Alumis Inc. Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Alumis Inc. Main Business Overview
  11.7.5 Alumis Inc. Latest Developments
11.8 Galapagos NV
  11.8.1 Galapagos NV Company Information
  11.8.2 Galapagos NV Oral TYK2 Inhibitor Product Offered
  11.8.3 Galapagos NV Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Galapagos NV Main Business Overview
  11.8.5 Galapagos NV Latest Developments
11.9 Ventyx Biosciences
  11.9.1 Ventyx Biosciences Company Information
  11.9.2 Ventyx Biosciences Oral TYK2 Inhibitor Product Offered
  11.9.3 Ventyx Biosciences Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Ventyx Biosciences Main Business Overview
  11.9.5 Ventyx Biosciences Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oral TYK2 Inhibitor Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Oral TYK2 Inhibitor Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single-target Inhibitor
Table 4. Major Players of Dual-target Inhibitor
Table 5. Oral TYK2 Inhibitor Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Oral TYK2 Inhibitor Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Oral TYK2 Inhibitor Market Size Market Share by Type (2021-2026)
Table 8. Oral TYK2 Inhibitor Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Oral TYK2 Inhibitor Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Oral TYK2 Inhibitor Market Size Market Share by Application (2021-2026)
Table 11. Global Oral TYK2 Inhibitor Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Oral TYK2 Inhibitor Revenue Market Share by Player (2021-2026)
Table 13. Oral TYK2 Inhibitor Key Players Head office and Products Offered
Table 14. Oral TYK2 Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Oral TYK2 Inhibitor Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Oral TYK2 Inhibitor Market Size Market Share by Region (2021-2026)
Table 19. Global Oral TYK2 Inhibitor Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Oral TYK2 Inhibitor Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Oral TYK2 Inhibitor Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Oral TYK2 Inhibitor Market Size Market Share by Country (2021-2026)
Table 23. Americas Oral TYK2 Inhibitor Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Oral TYK2 Inhibitor Market Size Market Share by Type (2021-2026)
Table 25. Americas Oral TYK2 Inhibitor Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Oral TYK2 Inhibitor Market Size Market Share by Application (2021-2026)
Table 27. APAC Oral TYK2 Inhibitor Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Oral TYK2 Inhibitor Market Size Market Share by Region (2021-2026)
Table 29. APAC Oral TYK2 Inhibitor Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Oral TYK2 Inhibitor Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Oral TYK2 Inhibitor Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Oral TYK2 Inhibitor Market Size Market Share by Country (2021-2026)
Table 33. Europe Oral TYK2 Inhibitor Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Oral TYK2 Inhibitor Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Oral TYK2 Inhibitor Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Oral TYK2 Inhibitor Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Oral TYK2 Inhibitor Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Oral TYK2 Inhibitor
Table 39. Key Market Challenges & Risks of Oral TYK2 Inhibitor
Table 40. Key Industry Trends of Oral TYK2 Inhibitor
Table 41. Global Oral TYK2 Inhibitor Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Oral TYK2 Inhibitor Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Oral TYK2 Inhibitor Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Oral TYK2 Inhibitor Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Bristol-Myers Squibb Details, Company Type, Oral TYK2 Inhibitor Area Served and Its Competitors
Table 46. Bristol-Myers Squibb Oral TYK2 Inhibitor Product Offered
Table 47. Bristol-Myers Squibb Oral TYK2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Bristol-Myers Squibb Main Business
Table 49. Bristol-Myers Squibb Latest Developments
Table 50. InnoCare Pharma Details, Company Type, Oral TYK2 Inhibitor Area Served and Its Competitors
Table 51. InnoCare Pharma Oral TYK2 Inhibitor Product Offered
Table 52. InnoCare Pharma Oral TYK2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. InnoCare Pharma Main Business
Table 54. InnoCare Pharma Latest Developments
Table 55. Takeda (Nimbus Therapeutics) Details, Company Type, Oral TYK2 Inhibitor Area Served and Its Competitors
Table 56. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitor Product Offered
Table 57. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Takeda (Nimbus Therapeutics) Main Business
Table 59. Takeda (Nimbus Therapeutics) Latest Developments
Table 60. E-nitiate Biopharmaceuticals Details, Company Type, Oral TYK2 Inhibitor Area Served and Its Competitors
Table 61. E-nitiate Biopharmaceuticals Oral TYK2 Inhibitor Product Offered
Table 62. E-nitiate Biopharmaceuticals Oral TYK2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. E-nitiate Biopharmaceuticals Main Business
Table 64. E-nitiate Biopharmaceuticals Latest Developments
Table 65. Highlightll Pharmaceutical Details, Company Type, Oral TYK2 Inhibitor Area Served and Its Competitors
Table 66. Highlightll Pharmaceutical Oral TYK2 Inhibitor Product Offered
Table 67. Highlightll Pharmaceutical Oral TYK2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Highlightll Pharmaceutical Main Business
Table 69. Highlightll Pharmaceutical Latest Developments
Table 70. Pfizer Details, Company Type, Oral TYK2 Inhibitor Area Served and Its Competitors
Table 71. Pfizer Oral TYK2 Inhibitor Product Offered
Table 72. Pfizer Oral TYK2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Pfizer Main Business
Table 74. Pfizer Latest Developments
Table 75. Alumis Inc. Details, Company Type, Oral TYK2 Inhibitor Area Served and Its Competitors
Table 76. Alumis Inc. Oral TYK2 Inhibitor Product Offered
Table 77. Alumis Inc. Oral TYK2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Alumis Inc. Main Business
Table 79. Alumis Inc. Latest Developments
Table 80. Galapagos NV Details, Company Type, Oral TYK2 Inhibitor Area Served and Its Competitors
Table 81. Galapagos NV Oral TYK2 Inhibitor Product Offered
Table 82. Galapagos NV Oral TYK2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Galapagos NV Main Business
Table 84. Galapagos NV Latest Developments
Table 85. Ventyx Biosciences Details, Company Type, Oral TYK2 Inhibitor Area Served and Its Competitors
Table 86. Ventyx Biosciences Oral TYK2 Inhibitor Product Offered
Table 87. Ventyx Biosciences Oral TYK2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Ventyx Biosciences Main Business
Table 89. Ventyx Biosciences Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Oral TYK2 Inhibitor Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral TYK2 Inhibitor Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Oral TYK2 Inhibitor Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Oral TYK2 Inhibitor Sales Market Share by Country/Region (2025)
Figure 8. Oral TYK2 Inhibitor Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Oral TYK2 Inhibitor Market Size Market Share by Type in 2025
Figure 10. Oral TYK2 Inhibitor in Psoriasis
Figure 11. Global Oral TYK2 Inhibitor Market: Psoriasis (2021-2026) & ($ millions)
Figure 12. Oral TYK2 Inhibitor in Atopic Dermatitis
Figure 13. Global Oral TYK2 Inhibitor Market: Atopic Dermatitis (2021-2026) & ($ millions)
Figure 14. Oral TYK2 Inhibitor in Other
Figure 15. Global Oral TYK2 Inhibitor Market: Other (2021-2026) & ($ millions)
Figure 16. Global Oral TYK2 Inhibitor Market Size Market Share by Application in 2025
Figure 17. Global Oral TYK2 Inhibitor Revenue Market Share by Player in 2025
Figure 18. Global Oral TYK2 Inhibitor Market Size Market Share by Region (2021-2026)
Figure 19. Americas Oral TYK2 Inhibitor Market Size 2021-2026 ($ millions)
Figure 20. APAC Oral TYK2 Inhibitor Market Size 2021-2026 ($ millions)
Figure 21. Europe Oral TYK2 Inhibitor Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Oral TYK2 Inhibitor Market Size 2021-2026 ($ millions)
Figure 23. Americas Oral TYK2 Inhibitor Value Market Share by Country in 2025
Figure 24. United States Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Oral TYK2 Inhibitor Market Size Market Share by Region in 2025
Figure 29. APAC Oral TYK2 Inhibitor Market Size Market Share by Type (2021-2026)
Figure 30. APAC Oral TYK2 Inhibitor Market Size Market Share by Application (2021-2026)
Figure 31. China Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 35. India Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Oral TYK2 Inhibitor Market Size Market Share by Country in 2025
Figure 38. Europe Oral TYK2 Inhibitor Market Size Market Share by Type (2021-2026)
Figure 39. Europe Oral TYK2 Inhibitor Market Size Market Share by Application (2021-2026)
Figure 40. Germany Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 41. France Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Oral TYK2 Inhibitor Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Oral TYK2 Inhibitor Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Oral TYK2 Inhibitor Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Oral TYK2 Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 54. APAC Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 55. Europe Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 57. United States Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 58. Canada Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 59. Mexico Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 60. Brazil Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 61. China Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 62. Japan Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 63. Korea Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 65. India Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 66. Australia Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 67. Germany Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 68. France Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 69. UK Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 70. Italy Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 71. Russia Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 72. Egypt Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 73. South Africa Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 74. Israel Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 75. Turkey Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)
Figure 76. Global Oral TYK2 Inhibitor Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Oral TYK2 Inhibitor Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Oral TYK2 Inhibitor Market Size 2027-2032 ($ millions)